Bath & Body Works (NYSE:BBWI – Free Report) had its target price raised by Deutsche Bank Aktiengesellschaft from $51.00 to $52.00 in a research report released on Tuesday,Benzinga reports. They currently have a buy rating on the stock.
A number of other brokerages have also issued reports on BBWI. Telsey Advisory Group restated an “outperform” rating and issued a $42.00 price target on shares of Bath & Body Works in a research note on Monday. The Goldman Sachs Group cut their target price on shares of Bath & Body Works from $60.00 to $49.00 and set a “buy” rating on the stock in a research note on Thursday, August 29th. UBS Group reduced their price target on shares of Bath & Body Works from $52.00 to $38.00 and set a “neutral” rating on the stock in a research report on Thursday, August 29th. BMO Capital Markets reissued an “outperform” rating and issued a $50.00 price objective (down from $52.00) on shares of Bath & Body Works in a report on Thursday, August 29th. Finally, JPMorgan Chase & Co. upped their price objective on Bath & Body Works from $35.00 to $39.00 and gave the company a “neutral” rating in a research note on Tuesday. One analyst has rated the stock with a sell rating, six have given a hold rating and nine have assigned a buy rating to the company. According to data from MarketBeat.com, Bath & Body Works presently has an average rating of “Moderate Buy” and an average price target of $41.88.
Check Out Our Latest Report on Bath & Body Works
Bath & Body Works Stock Performance
Bath & Body Works (NYSE:BBWI – Get Free Report) last announced its earnings results on Wednesday, August 28th. The company reported $0.37 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.35 by $0.02. The company had revenue of $1.53 billion for the quarter, compared to analyst estimates of $1.54 billion. Bath & Body Works had a negative return on equity of 44.03% and a net margin of 12.43%. As a group, research analysts predict that Bath & Body Works will post 3.18 EPS for the current year.
Bath & Body Works Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Friday, December 6th. Shareholders of record on Friday, November 22nd will be paid a dividend of $0.20 per share. This represents a $0.80 annualized dividend and a yield of 2.23%. The ex-dividend date of this dividend is Friday, November 22nd. Bath & Body Works’s payout ratio is currently 19.51%.
Insiders Place Their Bets
In related news, CEO Gina Boswell bought 6,000 shares of the stock in a transaction on Wednesday, October 9th. The shares were purchased at an average price of $29.64 per share, with a total value of $177,840.00. Following the purchase, the chief executive officer now owns 242,987 shares in the company, valued at approximately $7,202,134.68. This represents a 2.53 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available through this hyperlink. 0.27% of the stock is currently owned by insiders.
Institutional Inflows and Outflows
Several institutional investors and hedge funds have recently made changes to their positions in BBWI. First Community Trust NA bought a new stake in Bath & Body Works during the second quarter worth approximately $30,000. True Wealth Design LLC increased its position in shares of Bath & Body Works by 5,270.0% during the 3rd quarter. True Wealth Design LLC now owns 1,074 shares of the company’s stock valued at $34,000 after purchasing an additional 1,054 shares during the period. Livforsakringsbolaget Skandia Omsesidigt raised its stake in shares of Bath & Body Works by 300.0% in the 3rd quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 1,200 shares of the company’s stock worth $38,000 after buying an additional 900 shares in the last quarter. Wilmington Savings Fund Society FSB acquired a new stake in shares of Bath & Body Works in the third quarter valued at $39,000. Finally, TD Private Client Wealth LLC lifted its holdings in shares of Bath & Body Works by 24.2% in the third quarter. TD Private Client Wealth LLC now owns 1,697 shares of the company’s stock valued at $54,000 after buying an additional 331 shares during the period. 95.14% of the stock is currently owned by institutional investors.
Bath & Body Works Company Profile
Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.
Featured Stories
- Five stocks we like better than Bath & Body Works
- Best Aerospace Stocks Investing
- Eli Lilly, Pfizer, and AstraZeneca: 2025 Vaccine Makers to Watch
- What is the FTSE 100 index?
- DICK’S Sporting Goods: The Under-the-Radar Buy-and-Hold Winner
- What Are Some of the Best Large-Cap Stocks to Buy?
- 2 Cheap Quantum Computing Stocks to Buy Instead of Chasing IonQ
Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.